SoftOx Solutions AS
Research SoftOx Solutions AS (SOFTX) on Bullrun: market cap NOK 284.16M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSOFTX
- ExchangeOL
- CountryNorway
- SectorHealthcare
- IndustryBiotechnology
- CurrencyNOK
- Market capNOK 284.16M
- Financial periodQ4 2025
- RevenueNOK 3.61M
- Net income-NOK 3.88M
- Free cash flow-NOK 8.16M
Valuation Snapshot
latest market cap is NOK 284.16M.
About SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.
Frequently asked questions
What is SoftOx Solutions AS's market cap?
SoftOx Solutions AS's market capitalization is NOK 284.16M.
What does SoftOx Solutions AS do?
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections.